Zoetis Inc. (NYSE:ZTS) Shares Bought by Pacer Advisors Inc.

Pacer Advisors Inc. increased its position in Zoetis Inc. (NYSE:ZTS - Free Report) by 15.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 46,611 shares of the company's stock after buying an additional 6,237 shares during the quarter. Pacer Advisors Inc.'s holdings in Zoetis were worth $9,107,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Asset Dedication LLC raised its stake in shares of Zoetis by 4.8% in the 2nd quarter. Asset Dedication LLC now owns 1,174 shares of the company's stock valued at $204,000 after acquiring an additional 54 shares during the period. Forza Wealth Management LLC lifted its stake in shares of Zoetis by 1.8% during the second quarter. Forza Wealth Management LLC now owns 3,313 shares of the company's stock worth $574,000 after purchasing an additional 58 shares in the last quarter. Cherry Creek Investment Advisors Inc. lifted its stake in shares of Zoetis by 2.0% during the third quarter. Cherry Creek Investment Advisors Inc. now owns 3,021 shares of the company's stock worth $590,000 after purchasing an additional 58 shares in the last quarter. L. Roy Papp & Associates LLP boosted its position in shares of Zoetis by 2.8% in the second quarter. L. Roy Papp & Associates LLP now owns 2,221 shares of the company's stock worth $385,000 after buying an additional 60 shares during the period. Finally, Grove Bank & Trust grew its stake in shares of Zoetis by 0.5% in the third quarter. Grove Bank & Trust now owns 11,763 shares of the company's stock valued at $2,298,000 after buying an additional 61 shares in the last quarter. Institutional investors and hedge funds own 92.80% of the company's stock.

Analyst Ratings Changes

ZTS has been the subject of a number of analyst reports. Stifel Nicolaus upped their price target on Zoetis from $200.00 to $210.00 and gave the stock a "buy" rating in a report on Wednesday, September 18th. Argus raised shares of Zoetis to a "strong-buy" rating in a research note on Friday, August 9th. JPMorgan Chase & Co. upped their price objective on shares of Zoetis from $225.00 to $230.00 and gave the company an "overweight" rating in a research report on Friday, October 11th. Piper Sandler raised their target price on Zoetis from $195.00 to $210.00 and gave the company an "overweight" rating in a research note on Wednesday, August 14th. Finally, BTIG Research boosted their price target on Zoetis from $220.00 to $225.00 and gave the stock a "buy" rating in a research note on Monday, August 12th. Ten analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $221.44.

Zoetis Stock Performance

NYSE:ZTS traded up $0.25 during trading hours on Friday, reaching $176.96. 1,854,574 shares of the stock were exchanged, compared to its average volume of 2,832,691. The stock has a market capitalization of $79.84 billion, a P/E ratio of 33.26, a P/E/G ratio of 2.71 and a beta of 0.90. The firm has a 50 day simple moving average of $185.62 and a 200-day simple moving average of $180.72. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $201.92.

Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.12. The firm had revenue of $2.40 billion for the quarter, compared to analysts' expectations of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The firm's revenue for the quarter was up 11.6% on a year-over-year basis. During the same period last year, the business posted $1.36 earnings per share. As a group, sell-side analysts forecast that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Shareholders of record on Thursday, October 31st will be issued a $0.432 dividend. The ex-dividend date is Thursday, October 31st. This represents a $1.73 dividend on an annualized basis and a yield of 0.98%. Zoetis's dividend payout ratio is currently 32.52%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.